Dr. Menghuan Wang | Cognitive Rehabilitation | Young Scientist Award

Dr. Menghuan Wang | Cognitive Rehabilitation | Young Scientist Award šŸ†

Ph.D at Nanjing Normal University ,ChinašŸŽ“

šŸ‘Øā€šŸ”¬ Menghuan Wang is a dedicated PhD candidate in the field of neurorehabilitation at Nanjing Normal University, with previous academic affiliations at Nanjing Medical University. His research is centered on enhancing cognitive and motor function through non-invasive brain stimulation and innovative therapies. Wang has focused on impactful treatments for aphasia and stroke patients, as well as those undergoing maintenance hemodialysis.

 

Professional ProfileĀ 

Education šŸŽ“:

šŸŽ“ PhD Candidate, Nanjing Normal University – Specializing in neurorehabilitation, Wang’s academic training includes expertise in functional near-infrared spectroscopy (fNIRS) and advanced brain stimulation methods such as transcranial magnetic stimulation (TMS) and transcutaneous auricular vagus nerve stimulation (taVNS).

Work Experience šŸ’¼:

šŸ’¼ Research and Innovation – Wang has led and collaborated on significant research projects aimed at improving patient-centered neurorehabilitation, with 15 research publications in both English and Chinese journals. His work has influenced approaches to cognitive function restoration and non-invasive therapeutic techniques.

Skills šŸ”

  • Neurorehabilitation Techniques: Proficient in fNIRS, TMS, tES, and taVNS.
  • Patient-Centered Research: Developing therapies for patients with cognitive impairment and motor challenges, focusing on post-stroke recovery and cognitive decline prevention in dialysis patients.
  • Cognitive and Motor Function Restoration: Employing non-invasive brain stimulation to achieve measurable rehabilitation outcomes.

Awards and Honors šŸ†

šŸ† Award Nominee – Menghuan Wang is nominated for the Young Scientist Award and Best Researcher Award, recognizing his substantial contributions to cognitive science and neurorehabilitation. His work has garnered citations and recognition, particularly within Chinese and international scientific communities.

šŸ¤ Memberships:

šŸ¤ Professional Affiliations

  • Member, Branch of Cognitive Neurobiology, Chinese Neuroscience Society
  • Member, Chinese Association of Rehabilitation Medicine
    These memberships underscore Wang’s active engagement with prominent cognitive and rehabilitation networks.

Teaching Experience šŸ‘©ā€šŸ«:

Mentorship and Knowledge Sharing – As an advanced researcher, Wang frequently collaborates with peers, guiding team-based research projects and contributing to knowledge-building within his field.

Research Focus šŸ”¬:

Wang’s research focuses on cognitive neuroscience, neurolinguistics, and neuromodulation, with a particular emphasis on neurorehabilitation. His pioneering studies on taVNS for hemodialysis patients have shown promise in preventing cognitive impairment, offering new paths in non-invasive brain treatments.

ConclusionĀ 

Menghuan Wang’s research contributions make him a compelling candidate for the Young Scientist Award. His innovative use of non-invasive neuromodulation techniques in neurorehabilitation reflects both academic rigor and a commitment to patient-centered care. With a growing publication record and substantial clinical relevance, Wang shows strong potential to advance the field of cognitive neuroscience. Further expanding his collaborative and leadership roles could strengthen his profile even further, but his current accomplishments already showcase a high level of scientific achievement and innovation that aligns well with the spirit of the Young Scientist Award.

šŸ“š PublilcationĀ 

  • Transcutaneous Auricular Vagus Nerve Stimulation Combined with Task-Oriented Training to Improve Upper Extremity Function in Post-Stroke Hemiplegia
    • Year: 2024
    • Journal: Chinese Journal of Rehabilitation Medicine (Vol. 39, Issue 6, pp. 782–790)
    • Authors: Wang, M., Kong, Y., Xie, M.
  • ZNF217-Activated Notch Signaling Mediates Sulforaphane-Suppressed Stem Cell Properties in Colorectal Cancer
    • Year: 2024
    • Journal: Journal of Nutritional Biochemistry (Vol. 125, Article 109551)
    • Authors: Wang, M., Tang, L., Chen, S., Li, Y., Chen, Y.
  • Transcutaneous Auricular Vagus Nerve Stimulation Improves Cognitive Decline by Alleviating Intradialytic Cerebral Hypoxia in Hemodialysis Patients: A fNIRS Pilot Study
    • Year: 2024
    • Journal: Heliyon (Article e39841)
    • Authors: Wang, M.-H., Jin, Y.-J., He, M.-F., Li, W.-W., Jiang, Z.-L.
  • Transcutaneous Auricular Vagus Nerve Stimulation with Task-Oriented Training Improves Upper Extremity Function in Patients with Subacute Stroke: A Randomized Clinical Trial
    • Year: 2024
    • Journal: Frontiers in Neuroscience (Vol. 18, Article 1346634)
    • Authors: Wang, M.-H., Wang, Y.-X., Xie, M., Lin, F., Jiang, Z.-L.
  • Diallyl Trisulfide Inhibits Gastric Cancer Stem Cell Properties Through Ī”Np63/Sonic Hedgehog Pathway
    • Year: 2023
    • Journal: Molecular Carcinogenesis (Vol. 62, Issue 11, pp. 1673–1685)
    • Authors: Ge, M., Zhu, J., Yi, K., Jiang, Z., Han, H.
  • Transcranial Direct Current Stimulation Improves the Attention and Executive Function in Patients with Maintenance Hemodialysis
    • Year: 2023
    • Journal: Chinese Journal of Rehabilitation Medicine (Vol. 38, Issue 9, pp. 1221–1226)
    • Authors: Chen, L., Wang, M., Li, W.
  • TEADs Serve as Potential Prognostic Biomarkers and Targets for Human Gastric Cancer
    • Year: 2022
    • Journal: BMC Gastroenterology (Vol. 22, Issue 1, Article 308)
    • Authors: Wang, M.-H., Li, B.-Z., Chen, Y., Wang, J.
  • Ī”Np63α Mediates Sulforaphane-Suppressed Colorectal Cancer Stem Cell Properties Through Transcriptional Regulation of Nanog/Oct4/Sox2
    • Year: 2022
    • Journal: Journal of Nutritional Biochemistry (Vol. 107, Article 109067)
    • Authors: Chen, Y., Wang, M.-H., Wu, J.-Y., Han, H.-Y., Zhong, C.-Y.
  • TAp63α Targeting of Lgr5 Mediates Colorectal Cancer Stem Cell Properties and Sulforaphane Inhibition
    • Year: 2020
    • Journal: Oncogenesis (Vol. 9, Issue 10, Article 89)
    • Authors: Chen, Y., Wang, M.-H., Zhu, J.-Y., Han, H.-Y., Zhong, C.-Y.

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award šŸ†

Division of Diabetes and Nutrition at RARiS, Tohoku University,Ā Japan
šŸŽ“

Dr. Katsunori Nonogaki is a distinguished professor and clinical specialist in diabetes and internal medicine, holding extensive expertise in lifestyle medicine and diabetes research. He obtained his MD in Japan in 1987, followed by a PhD from Nagoya University Graduate School of Medicine in 1993. His postdoctoral training included positions at UCSF and The Scripps Research Institute, where he focused on metabolism and neuropharmacology. Dr. Nonogaki has held key academic roles at prestigious institutions, including the University of Tokyo and Tohoku University, where he has been a professor since 2008.

Professional ProfileĀ 

šŸ“š Work Experience & Teaching

Dr. Nonogaki has a long-standing academic career, beginning as a lecturer at the University of Tokyo before joining Tohoku University in various professorial roles. His teaching experience spans undergraduate to postgraduate levels, where he mentors future leaders in diabetes research and metabolic health.

šŸŽ–ļø Skills, Awards, and Honors

Dr. Nonogaki is highly skilled in molecular nutrition, metabolic diseases, and translational research. He has served as the Chief of the Laboratory of Molecular Nutrition and is recognized for his contributions to diabetes research, earning several awards in this domain. He has also made impactful contributions to scientific literature, serving on the editorial boards of key journals such as Frontiers in Endocrinology and Diabetes Research and Clinical Practice.

🌐 Memberships & Professional Involvement

His professional involvement extends to numerous editorial roles, including Topic Editor and Associate Editor in leading journals. Dr. Nonogaki is a highly regarded member of the international diabetes research community, where he actively contributes to advancements in metabolic health and diabetes management.

Research Focus

Xiaofeng’s research is centered on entrepreneurial behavior, project selection, and risk assessment. He has proposed a three-stage theory for project selection and developed a dynamic measurement model for entrepreneurial risks. His work has practical implications, particularly in the evaluation of risks in family farms and entrepreneurship education. His 65 published journal articles and various patents further underscore his contributions to the field.

 

Publications :Ā 

“The GLP-1 Receptor Agonist Liraglutide Decreases Primary Bile Acids and Serotonin in the Colon Independently of Feeding in Mice”
Year: 2024
Journal: International Journal of Molecular Sciences